| Literature DB >> 8069675 |
S Kapur1, J Meyer, A A Wilson, S Houle, G M Brown.
Abstract
This study investigates the effect of a serotonergic agent, fenfluramine, on neuronal activity, as measured using [18F]fluorodeoxyglucose (FDG) uptake with positron emission tomography (PET) in humans. Eleven subjects each received oral fenfluramine and placebo, on two different occasions, followed by FDG PET scans. Our study shows that fenfluramine modulates ongoing neuronal activity in a regionally specific fashion with a relative increase in metabolism in the prefrontal cortex and a relative decrease in the occipital-temporal regions.Entities:
Mesh:
Substances:
Year: 1994 PMID: 8069675 DOI: 10.1016/0006-8993(94)90091-4
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252